Goldman Sachs Starts ISIS Pharmaceuticals (ISIS) at Neutral
Tweet Send to a Friend
Goldman Sachs initiated coverage on ISIS Pharmaceuticals (NASDAQ: ISIS) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE